Cilostazol Shows Promise as Potential Oral Therapy for Raynaud’s Phenomenon in SSc Patients
News
Researchers found that the oral drug cilostazol is a potential oral therapy for ameliorating Raynaud’s phenomenon in patients with systemic sclerosis (SSc). The study “Efficacy of cilostazol for the treatment ... Read more